AISAP

Company Overview

Snapshot

Founded in January 2022 by Adiel Am-Shalom and Ehud Raanani, AISAP operates with 11–50 employees. The company has secured $13 million across two funding rounds from two investors. In August 2024, AISAP received FDA approval for its CARDIO AI-powered Point-of-Care Ultrasound Diagnostic Software.

Business overview

AISAP supports clinicians with point-of-care ultrasound solutions, offering real-time acquisition guidance, immediate interpretation, and multi-organ diagnoses. The company's core product, POCAD, is an intuitive, secure cloud-based platform that leverages AI to provide ultrasound diagnoses anywhere and at any time. This technology empowers clinicians and connects care teams to deliver efficient and rapid treatment at the patient's bedside. AISAP operates within the Health Tech & Life Sciences sector, specifically targeting digital healthcare and digital medical diagnostics markets.

Strategic signal

In November 2025, AISAP launched a landmark field initiative in Ghana, deploying its FDA-cleared technology to address rural health challenges. This initiative demonstrates the company's commitment to expanding access to advanced diagnostic tools in underserved regions and provides a blueprint for tackling cardiology deserts, signaling strong potential for market expansion and impact in both developing and developed healthcare systems.

Company Intelligence Q&A

What was a significant recent recognition for AISAP?

In March 2025, AISAP was named to Fast Company’s List of the World’s Most Innovative Companies of 2025, recognizing its advancements in AI Point-of-Care Diagnostics.

What was a key regulatory milestone for AISAP?

In August 2024, AISAP received FDA approval for its CARDIO AI-powered Point-of-Care Ultrasound Diagnostic Software, enabling its use for cardiac diagnosis.

What was AISAP's most recent funding round?

In May 2024, AISAP raised $13 million in a Seed funding round, with investments from Shoni Health Ventures and Harel Insurance & Finance.

How is AISAP contributing to healthcare in rural areas?

In November 2025, AISAP announced a landmark field initiative in Ghana, deploying its FDA-cleared technology to address rural health challenges and provide a blueprint for cardiology deserts.

What was an early strategic partnership for AISAP?

In July 2023, AISAP was selected as one of 10 Israeli companies for Assuta's 'RISE With US' program, indicating early validation and collaboration within the healthcare ecosystem.